The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations

被引:0
作者
Kocabey, Duygu Unal [1 ]
Cakir, I. Ebru [1 ]
机构
[1] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Pathol, Izmir, Turkiye
关键词
Colorectal carcinoma; Growth pattern; Tumor budding; Poorly differentiated clusters; Desmoplastic reaction pattern; Tumor-stroma ratio; KRAS; STAGE-II; LYMPHOCYTIC INFILTRATION; BORDER CONFIGURATION; K-RAS; COLON; SURVIVAL; KRAS; FEATURES; SYSTEM; MICROENVIRONMENT;
D O I
10.1016/j.anndiagpath.2024.152375
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Growth pattern (GP), tumor budding (TB), poorly differentiated clusters (PDC), desmoplastic reaction pattern (DRP) and tumor-stroma ratio (TSR) are prognostic histomorphological parameters in colorectal cancer (CRC). Correlations between these parameters, their individual prognostic values, and their relationship with KRAS/ NRAS/BRAF mutations have not been comprehensively examined. We aimed to investigate these associations, which have not been previously explored in this combination. 126 CRC cases were included. GP, TB, PDC, DRP and TSR were evaluated by two experienced pathologists. KRAS/NRAS/BRAF / BRAF mutation profile were determined using qPCR. Demographic, clinicopathological and survival data were recorded. Interrelations were investigated by statistical analysis. Infiltrative GP was more frequent in high-score TB, PDC-G3, and stroma-high tumors (p p 0.05). High-score TB was more common in PDC-G3 and stroma-high tumors (p < 0.05). Immature DRP was more frequent in stroma-high tumors (p p = 0.014). Among histomorphological parameters, a significant relationship was found only between infiltrative GP and the presence of KRAS mutation (p p = 0.023). Moreover, GP was significantly associated with pT, lymphatic invasion, perineural invasion (p p < 0.05). Effects on survival were assessed using Kaplan-Meier method and Cox proportional hazards model. TB and PDC were identified as independent predictors of overall survival. Higher TB score (p p = 0.008) and higher PDC grade (p p = 0.013) lead to worse survival. Interestingly, GP, DRP, , TSR or KRAS/NRAS/BRAF mutations were not associated with overall survival. Our results highlight the prognostic significance of TB and PDC. We suggest incorporating TB and PDC into routine CRC reports. The association of KRAS mutation with infiltrative GP supports its role in the acquisition of invasive behavior.
引用
收藏
页数:13
相关论文
共 74 条
  • [11] Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer
    Fujiyoshi, Kenji
    Vayrynen, Juha P.
    Borowsky, Jennifer
    Papke, David J., Jr.
    Arima, Kota
    Haruki, Koichiro
    Kishikawa, Junko
    Akimoto, Naohiko
    Ugai, Tomotaka
    Lau, Mai Chan
    Gu, Simeng
    Shi, Shanshan
    Zhao, Melissa
    Da Silva, Annacarolina Fabiana Lucia
    Twombly, Tyler S.
    Nan, Hongmei
    Meyerhardt, Jeffrey A.
    Song, Mingyang
    Zhang, Xuehong
    Wu, Kana
    Chan, Andrew T.
    Fuchs, Charles S.
    Lennerz, Jochen K.
    Giannakis, Marios
    Nowak, Jonathan A.
    Ogino, Shuji
    [J]. EBIOMEDICINE, 2020, 57
  • [12] Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
    Gao, Jinlai
    Shen, Zhangguo
    Deng, Zaixing
    Mei, Lina
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [13] Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer
    Gonzalez, I. A.
    Bauer, P. S.
    Liu, J.
    Chatterjee, D.
    [J]. HISTOPATHOLOGY, 2021, 78 (02) : 252 - 264
  • [14] Tumor Budding in Colorectal Carcinoma Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort
    Graham, Rondell P.
    Vierkant, Robert A.
    Tillmans, Lori S.
    Wang, Alice H.
    Laird, Peter W.
    Weisenberger, Daniel J.
    Lynch, Charles F.
    French, Amy J.
    Slager, Susan L.
    Raissian, Yassaman
    Garcia, Joaquin J.
    Kerr, Sarah E.
    Lee, Hee Eun
    Thibodeau, Stephen N.
    Cerhan, James R.
    Limburg, Paul J.
    Smyrk, Thomas C.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (10) : 1340 - 1346
  • [15] KRAS Mutations are Associated With Specific Morphologic Features in Colon Cancer
    Gunal, Armagan
    Hui, Pei
    Kilic, Selim
    Xu, Ruliang
    Jain, Dhanpat
    Mitchell, Kisha
    Robert, Marie
    Kenney, Barton
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (06) : 509 - 514
  • [16] Immature Stroma and Prognostic Profiling in Colorectal Carcinoma: Development and Validation of Novel Classification Systems
    Hacking, Sean
    Ebare, Kingsley
    Angert, Mallorie
    Lee, Lili
    Vitkovski, Taisia
    Thomas, Rebecca
    Chavarria, Hector
    Jin, Cao
    Nasim, Mansoor
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (07)
  • [17] Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
    Haigis, Kevin M.
    Kendall, Krystle R.
    Wang, Yufang
    Cheung, Ann
    Haigis, Marcia C.
    Glickman, Jonathan N.
    Niwa-Kawakita, Michiko
    Sweet-Cordero, Alejandro
    Sebolt-Leopold, Judith
    Shannon, Kevin M.
    Settleman, Jeffrey
    Giovannini, Marco
    Jacks, Tyler
    [J]. NATURE GENETICS, 2008, 40 (05) : 600 - 608
  • [18] Systematic review of tumour budding and association with common mutations in patients with colorectal cancer
    Hatthakarnkul, Phimmada
    Quinn, Jean A.
    Matly, Amna Ahmed Mohemmd
    Ammar, Aula
    van Wyk, Hester C.
    McMillan, Donald C.
    Edwards, Joanne
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 167
  • [19] The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
    Huijbers, A.
    Tollenaar, R. A. E. M.
    v Pelt, G. W.
    Zeestraten, E. C. M.
    Dutton, S.
    McConkey, C. C.
    Domingo, E.
    Smit, V. T. H. B. M.
    Midgley, R.
    Warren, B. F.
    Johnstone, E. C.
    Kerr, D. J.
    Mesker, W. E.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (01) : 179 - 185
  • [20] BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status
    Jang, Min Hye
    Kim, Sehun
    Hwang, Dae Yong
    Kim, Wook Youn
    Lim, So Dug
    Kim, Wan Seop
    Hwang, Tea Sook
    Han, Hye Seung
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (01) : 38 - 46